UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Inhibition of hypothalamic thyrotropin-releasing hormone messenger ribonucleic acid during food deprivation

Endocrinology (Philadelphia), 1991-11, Vol.129 (5), p.2714-2718

1991

Volltextzugriff (PDF)

Osmotic regulation of hypothalamo-neurointermediate lobe corticotrophin-releasing factor-41 in the rat

Journal of endocrinology, 1989-01, Vol.120 (1), p.119-124

1989

Volltextzugriff (PDF)

Effect of food deprivation and altered thyroid status on the hypothalamic-pituitary-thyroid axis in the rat

Journal of endocrinology, 1992-05, Vol.133 (2), p.183-188

1992

Volltextzugriff (PDF)

Immunoreactive vasopressin and oxytocin in hypothalamo-hypophysial portal blood of the Brattleboro and Long-Evans rat: effect of adrenalectomy and dexamethasone

Journal of endocrinology, 1988-04, Vol.117 (1), p.27-34

1988

Volltextzugriff (PDF)

Evidence for arginine vasopressin as the primary activator of the HPA axis during adjuvant‐induced arthritis

British journal of pharmacology, 1995-11, Vol.116 (5), p.2417-2424

1995

Volltextzugriff (PDF)

Reproducibility and comparability of insulin sensitivity indices measured by stable-label intravenous glucose tolerance test

Diabetic medicine, 1998-03, Vol.15 (3), p.234-246

1998

Volltextzugriff (PDF)

The effects of oral sumatriptan, a 5‐HT1 receptor agonist, on circulating ACTH and cortisol concentrations in man

British journal of clinical pharmacology, 1995-04, Vol.39 (4), p.389-395

1995

Volltextzugriff (PDF)

Constant infusion and bolus injection of stable-label tracer give reproducible and comparable fasting HGO

American journal of physiology: endocrinology and metabolism, 1997-07, Vol.36 (1), p.E192-E201

1997

Volltextzugriff (PDF)

Corticotrophin-releasing factor and arginine vasopressin in the hypothalamo-hypophyseal portal blood of rats following high-dose glucocorticoid treatment and withdrawal

Brain research, 1991-12, Vol.568 (1), p.311-313

1991

Volltextzugriff (PDF)

A pituitary tuberculoma

Journal of neurology, neurosurgery and psychiatry, 1987-03, Vol.50 (3), p.360-361

1987

Volltextzugriff (PDF)

Hypothalamo-hypophysial blood flow: a novel control mechanism in pituitary function?

Journal of endocrinology, 1987-04, Vol.113 (1), p.R1-R2

1987

Volltextzugriff (PDF)

Differential effects of hypothalamic catecholamine depletion on the release of arginine vasopressin and CRF-41 into hypothalamo-hypophyseal portal blood

Neuroscience letters, 1988-08, Vol.90 (3), p.292-296

1988

Volltextzugriff (PDF)

The TSH, T 4 , T 3 and prolactin responses to consecutive infusions of a potent and stabilized thyrotrophin releasing hormone analogue, RX77368, in man

European journal of clinical investigation, 1988-08, Vol.18 (4), p.405-409

1988

Volltextzugriff (PDF)

Neurotensin in hypothalamo-hypophyseal portal blood

Brain research, 1987-09, Vol.421 (1), p.161-166

1987

Volltextzugriff (PDF)

The TSH, T4, T3 and prolactin responses to consecutive infusions of a potent and stabilized thyrotrophin releasing hormone analogue, RX77368, in man

European journal of clinical investigation, 1988-08, Vol.18 (4), p.405-409

1988

Volltextzugriff (PDF)

Hypothalamo-hypophyseal portal blood sampling from laboratory rats: the effects of endocrine manipulations on portal blood catecholamine concentrations

Experimental brain research, 1988-01, Vol.72 (3), p.640-644

1988

Volltextzugriff (PDF)

Electrophysiological observations in patients with motor neuron disease receiving a thyrotropin releasing hormone analogue (RX77368)

Journal of neurology, neurosurgery and psychiatry, 1987-12, Vol.50 (12), p.1633-1640

1987

Volltextzugriff (PDF)

Controlled acute trial of a thyrotrophin releasing hormone analogue (RX77368) in motor neuron disease

Journal of neurology, neurosurgery and psychiatry, 1987-10, Vol.50 (10), p.1359-1370

1987

Volltextzugriff (PDF)

“I know my body better than anyone else”: a qualitative study of perspectives of people with lived experience on antimicrobial treatment decisions for injection drug use-associated infections

Therapeutic advances in infectious disease, 2023-01, Vol.10

2023

Volltextzugriff (PDF)

Comparison of Effect of Pioglitazone With Metformin or Sulfonylurea (Monotherapy and Combination Therapy) on Postload Glycemia and Composite Insulin Sensitivity Index During an Oral Glucose Tolerance Test in Patients With Type 2 Diabetes

Diabetes care, 2005-02, Vol.28 (2), p.266-272

2005

Volltextzugriff (PDF)

Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: Results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group study

Clinical therapeutics, 2005-05, Vol.27 (5), p.554-567

2005

Volltextzugriff (PDF)

PROactive study

The Lancet (British edition), 2006-03, Vol.367 (9515), p.982-982

2006

Volltextzugriff (PDF)

Constant infusion and bolus injection of stable-label tracer give reproducible and comparable fasting HGO

American journal of physiology: endocrinology and metabolism, 1997-07, Vol.273 (1), p.E192-E201

1997

Volltextzugriff (PDF)

Establishing the dose response curve for metabolic control with troglitazone, an insulin action enhancer, in type 2 diabetes patients

Annals of medicine (Helsinki), 1998, Vol.30 (2), p.206-212

1998

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(35)
Berichte
(1)

Sprache

Englisch
(36)

Erscheinungsjahr

n.n

Thema

Male
(22)
Life Sciences & Biomedicine
(21)
Science & Technology
(21)
Biological And Medical Sciences
(20)
Humans
(18)
Adult
(12)
Medical Sciences
(12)
Animals
(10)
Middle Aged
(10)
Rats
(10)
Rats, Inbred Strains
(9)
Female
(8)
Fundamental And Applied Biological Sciences. Psychology
(8)
Neurosciences & Neurology
(7)
Pharmacology. Drug Treatments
(7)
Pyrrolidonecarboxylic Acid - Analogs & Derivatives
(7)
Aged
(6)
Endocrinology & Metabolism
(6)
Diabetes
(5)
Diabetes Mellitus, Type 2 - Drug Therapy
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Inhibition of hypothalamic thyrotropin-releasing hormone messenger ribonucleic acid during food deprivation

Osmotic regulation of hypothalamo-neurointermediate lobe corticotrophin-releasing factor-41 in the rat

Effect of food deprivation and altered thyroid status on the hypothalamic-pituitary-thyroid axis in the rat

Immunoreactive vasopressin and oxytocin in hypothalamo-hypophysial portal blood of the Brattleboro and Long-Evans rat: effect of adrenalectomy and dexamethasone

Evidence for arginine vasopressin as the primary activator of the HPA axis during adjuvant‐induced arthritis

Reproducibility and comparability of insulin sensitivity indices measured by stable-label intravenous glucose tolerance test

The effects of oral sumatriptan, a 5‐HT1 receptor agonist, on circulating ACTH and cortisol concentrations in man

Constant infusion and bolus injection of stable-label tracer give reproducible and comparable fasting HGO

Corticotrophin-releasing factor and arginine vasopressin in the hypothalamo-hypophyseal portal blood of rats following high-dose glucocorticoid treatment and withdrawal

A pituitary tuberculoma

Hypothalamo-hypophysial blood flow: a novel control mechanism in pituitary function?

Differential effects of hypothalamic catecholamine depletion on the release of arginine vasopressin and CRF-41 into hypothalamo-hypophyseal portal blood

The TSH, T 4 , T 3 and prolactin responses to consecutive infusions of a potent and stabilized thyrotrophin releasing hormone analogue, RX77368, in man

Neurotensin in hypothalamo-hypophyseal portal blood

The TSH, T4, T3 and prolactin responses to consecutive infusions of a potent and stabilized thyrotrophin releasing hormone analogue, RX77368, in man

Hypothalamo-hypophyseal portal blood sampling from laboratory rats: the effects of endocrine manipulations on portal blood catecholamine concentrations

Electrophysiological observations in patients with motor neuron disease receiving a thyrotropin releasing hormone analogue (RX77368)

Controlled acute trial of a thyrotrophin releasing hormone analogue (RX77368) in motor neuron disease

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

“I know my body better than anyone else”: a qualitative study of perspectives of people with lived experience on antimicrobial treatment decisions for injection drug use-associated infections

Comparison of Effect of Pioglitazone With Metformin or Sulfonylurea (Monotherapy and Combination Therapy) on Postload Glycemia and Composite Insulin Sensitivity Index During an Oral Glucose Tolerance Test in Patients With Type 2 Diabetes

Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: Results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group study

PROactive study

Constant infusion and bolus injection of stable-label tracer give reproducible and comparable fasting HGO

Establishing the dose response curve for metabolic control with troglitazone, an insulin action enhancer, in type 2 diabetes patients

Suchergebnisse filtern